Mr. W. Clark Kent reports

CHROMEDX ENGAGES BIOSENSOR DEVELOPMENT EXPERT STEPHEN COZZETTE

ChroMedX Corp. has engaged Stephen Cozzette as a consultant on the HemoPalm project, focusing on the electrochemical sensor and cartridge development aspects of the project.

"We are very excited to add Stephens's expertise to the team. Mr. Cozzette is particularly skillful at integrating design controls in an entrepreneurial reality, and his background in the area of electrochemical sensor and cartridge development will greatly assist our efforts in producing a market-leading technology," said Dr. Wayne Maddever, ChroMedX president and chief executive officer.

Mr. Cozzette has 25-plus years experience in sensor and cartridge development, having played a major leadership role in this area with a large multinational point-of-care testing company. He provides guidance and structure in moving from science to solution, and premanufacturing to full production.

"I am pleased to be working with the ChroMedX team, an extremely creative and competent group. I believe that the HemoPalm has some significant technical advances over current devices available in the market and promises to be a significant advancement in point-of-care testing," said Mr. Cozzette.

We seek Safe Harbor.